{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:30:09Z","timestamp":1793161809089,"version":"4.5.0"},"reference-count":133,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI20\/00763"],"award-info":[{"award-number":["PI20\/00763"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["CPII20\/00022"],"award-info":[{"award-number":["CPII20\/00022"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Regional Development Fund FEDER"},{"name":"SENEFRO Foundation"},{"DOI":"10.13039\/100015883","name":"Spanish Society of Nephrology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is projected to become a leading global cause of death by 2040, and its early detection is critical for effective and timely management. The current definition of CKD identifies only advanced stages, when kidney injury has already destroyed &amp;gt;50% of functioning kidney mass as reflected by an estimated glomerular filtration rate &amp;lt;60 mL\/min\/1.73 m2 or a urinary albumin\/creatinine ratio &amp;gt;six-fold higher than physiological levels (i.e. &amp;gt; 30 mg\/g). An elevated urinary albumin-excretion rate is a known early predictor of future cardiovascular events. There is thus a \u2018blind spot\u2019 in the detection of CKD, when kidney injury is present but is undetectable by current diagnostic criteria, and no intervention is made before renal and cardiovascular damage occurs. The present review discusses the CKD \u2018blind spot\u2019 concept and how it may facilitate a holistic approach to CKD and cardiovascular disease prevention and implement the call for albuminuria screening implicit in current guidelines. Cardiorenal risk associated with albuminuria in the high-normal range, novel genetic and biochemical markers of elevated cardiorenal risk, and the role of heart and kidney protective drugs evaluated in recent clinical trials are also discussed. As albuminuria is a major risk factor for cardiovascular and renal disease, starting from levels not yet considered in the definition of CKD, the implementation of opportunistic or systematic albuminuria screening and therapy, possibly complemented with novel early biomarkers, has the potential to improve cardiorenal outcomes and mitigate the dismal 2040 projections for CKD and related cardiovascular burden.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehac683","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T08:26:20Z","timestamp":1668068780000},"page":"1112-1123","source":"Crossref","is-referenced-by-count":105,"title":["Prevention of cardiorenal damage: importance of albuminuria"],"prefix":"10.1093","volume":"44","author":[{"given":"Luis M","family":"Ruilope","sequence":"first","affiliation":[{"name":"Cardiorenal Translational Laboratory, Institute of Research Imas12, Hospital Universitario , 12 de Octubre, Avenida de C\u00f3rdoba s\/n , Spain"},{"name":"CIBER-CV, Hospital Universitario , Av. de C\u00f3rdoba s\/n, 28041, Madrid , Spain"},{"name":"Faculty of Sport Sciences, Universidad Europea de Madrid , Tajo, s\/n, 28670 Villaviciosa de Od\u00f3n, Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[{"name":"IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid , Av. de los Reyes Cat\u00f3licos, 2, 28040 Madrid , Spain"},{"name":"RICORS2040, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-0997","authenticated-orcid":false,"given":"Alejandro","family":"Lucia","sequence":"additional","affiliation":[{"name":"Faculty of Sport Sciences, Universidad Europea de Madrid , Tajo, s\/n, 28670 Villaviciosa de Od\u00f3n, Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Miranda","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n Renal \u00cd\u00f1igo \u00c1lvarez de Toledo , Jos\u00e9 Abascal, 42, 28003 Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Alvarez-Llamas","sequence":"additional","affiliation":[{"name":"IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid , Av. de los Reyes Cat\u00f3licos, 2, 28040 Madrid , Spain"},{"name":"RICORS2040, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Barderas","sequence":"additional","affiliation":[{"name":"Department of Vascular Physiopathology, Hospital Nacional de Parapl\u00e9jicos (HNP), SESCAM , FINCA DE, Carr. de la Peraleda, S\/N, 45004 Toledo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-8380","authenticated-orcid":false,"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome and IRCCS San Raffaele Rome , Sant'Andrea Hospital, Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-0915","authenticated-orcid":false,"given":"Gema","family":"Ruiz-Hurtado","sequence":"additional","affiliation":[{"name":"Cardiorenal Translational Laboratory, Institute of Research Imas12, Hospital Universitario , 12 de Octubre, Avenida de C\u00f3rdoba s\/n , Spain"},{"name":"CIBER-CV, Hospital Universitario , Av. de C\u00f3rdoba s\/n, 28041, Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-275X","authenticated-orcid":false,"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Michigan School of Medicine , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ckj\/sfab170","article-title":"RICORS2040: the need for collaborative research in chronic kidney disease","volume":"15","author":"Ortiz","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"2023040302304223100_"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/HJH.0000000000000147","article-title":"Association between albuminuria, atherosclerotic plaques, elevated pulse wave velocity, age, risk category and prognosis in apparently healthy individuals","volume":"32","author":"Greve","year":"2014","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/HJH.0b013e328356c579","article-title":"Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH\/ESC risk charts","volume":"30","author":"Sehestedt","year":"2012","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ckj\/sfx023","article-title":"Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase","volume":"10","author":"Sanchez-Ni\u00f1o","year":"2017","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.2007-3594","article-title":"Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents","volume":"121","author":"Nguyen","year":"2008","journal-title":"Pediatrics"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmjopen-2017-020262","article-title":"Albuminuria: population epidemiology and concordance in Australian children aged 11-12 years and their parents","volume":"9","author":"Larkins","year":"2019","journal-title":"BMJ Open"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS ONE"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ckj\/sfz125","article-title":"Klotho, the elusive kidney-derived anti-ageing factor","volume":"13","author":"Sanchez-Ni\u00f1o","year":"2020","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/ckj\/sfab240","article-title":"More on the invisibility of chronic kidney disease\u2026 and counting","volume":"15","author":"Carriazo","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/eurheartj\/ehab456","article-title":"Use of chronic kidney disease blind spot to prevent cardiorenal outcomes","volume":"43","author":"Ruilope","year":"2022","journal-title":"Eur Heart J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-154-5-201103010-00005","article-title":"Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study","volume":"154","author":"Clase","year":"2011","journal-title":"Ann Intern Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","article-title":"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies","volume":"7","author":"Coresh","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ekir.2018.01.015","article-title":"Mild albuminuria is a risk factor for faster GFR decline in the nondiabetic population","volume":"3","author":"Melsom","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/ckj\/sfac019","article-title":"The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high\/high cardiovascular risk among patients with chronic kidney disease","volume":"15","author":"Cebrian","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","first-page":"5","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"29","author":"Visseren","year":"2022","journal-title":"Eur Heart J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ekir.2018.04.004","article-title":"Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account","volume":"3","author":"Smith","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/0886022X.2013.779907","article-title":"Microalbuminuria screening for detecting chronic kidney disease in the general population: a systematic review","volume":"35","author":"Wu","year":"2013","journal-title":"Ren Fail"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","article-title":"Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium","volume":"78","author":"Shin","year":"2021","journal-title":"Hypertension"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/ckj\/sfac007","article-title":"Evidence of chronic kidney injury in patients not meeting KDIGO criteria for chronic kidney disease","volume":"15","author":"Alvarez-Llamas","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_"},{"key":"2023040302304223100_"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"74","DOI":"10.34067\/KID.0003912021","article-title":"Albuminuria within the normal range can predict all-cause mortality and cardiovascular mortality","volume":"3","author":"Kang","year":"2022","journal-title":"Kidney360"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"857983","DOI":"10.3389\/fendo.2022.857983","article-title":"Editorial: management of diabetes and its complications: a focus on endothelial dysfunction","volume":"13","author":"Qiu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"e1920964","DOI":"10.1001\/jamanetworkopen.2019.20964","article-title":"Adverse pregnancy outcomes and long-term maternal kidney disease: a systematic review and metaanalysis","volume":"3","author":"Barrett","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/ckj\/sfab273","article-title":"The ERA Registry Annual Report 2019: summary and age comparisons","volume":"15","author":"Boenink","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1053\/j.ajkd.2022.02.011","article-title":"Moving toward a common pathogenic mechanism and therapeutic targets for APOL1 nephropathies","volume":"79","author":"Bruggeman","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ckj\/sfaa112","article-title":"Kidney disease and electrolytes in COVID-19: more than meets the eye","volume":"13","author":"Carriazo","year":"2020","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2010060598","article-title":"CUBN is a gene locus for albuminuria","volume":"22","author":"B\u00f6ger","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jama.2021.0247","article-title":"Associations of maternal cardiovascular health in pregnancy with offspring cardiovascular health in early adolescence","volume":"325","author":"Perak","year":"2021","journal-title":"JAMA"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"769734","DOI":"10.3389\/fmed.2021.769734","article-title":"Prematurity and low birth weight in neonates as a risk factor for obesity, hypertension, and chronic kidney disease in pediatric and adult age","volume":"8","author":"Grillo","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-011-1843-8","article-title":"Human nephron number: implications for health and disease","volume":"26","author":"Bertram","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMoa020549","article-title":"Nephron number in patients with primary hypertension","volume":"348","author":"Keller","year":"2003","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"l1346","DOI":"10.1136\/bmj.l1346","article-title":"Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study","volume":"365","author":"Crump","year":"2019","journal-title":"BMJ"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.ajkd.2017.06.030","article-title":"Prenatal growth and CKD in older adults: longitudinal findings from the Helsinki birth cohort study, 1924-1944","volume":"71","author":"Eriksson","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ajkd.2019.02.018","article-title":"Association of low birth weight with childhood proteinuria at age 3 years: a population-based retrospective cohort study","volume":"74","author":"Shinzawa","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.117.10529","article-title":"Determinants of cardiometabolic risk factors in the first decade of life: a longitudinal study starting at birth","volume":"71","author":"Lurbe","year":"2018","journal-title":"Hypertension"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fped.2020.00230","article-title":"Albuminuria, hypertension, and reduced kidney volumes in adolescents born extremely premature","volume":"8","author":"Sanderson","year":"2020","journal-title":"Front Pediatr"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamacardio.2021.0961","article-title":"Association of systolic blood pressure elevation with disproportionate left ventricular remodeling in very preterm-born young adults: the preterm heart and elevated blood pressure","volume":"6","author":"Mohamed","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/HYPERTENSIONAHA.118.10975","article-title":"Trajectories of childhood blood pressure and adult left ventricular hypertrophy: the Bogalusa Heart Study","volume":"72","author":"Zhang","year":"2018","journal-title":"Hypertension"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1097\/HJH.0b013e32834d0ca1","article-title":"The impact of birth weight on blood pressure and arterial stiffness in later life: the Enigma Study","volume":"29","author":"Miles","year":"2011","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2261-12-89","article-title":"High-normal blood pressure and long-term risk of type 2 diabetes: 35-year prospective population based cohort study of men","volume":"12","author":"Stahl","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/HYPERTENSIONAHA.121.17766","article-title":"Isolated diastolic hypertension in the IDACO study: an age-stratified analysis using 24-hour ambulatory blood pressure measurements","volume":"78","author":"McEvoy","year":"2021","journal-title":"Hypertension"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11886-021-01609-w","article-title":"Is isolated diastolic hypertension an important phenotype?","volume":"23","author":"Romero","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/HJH.0b013e32834d9e0f","article-title":"Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression","volume":"30","author":"Cerezo","year":"2012","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa013410","article-title":"Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes","volume":"347","author":"Lurbe","year":"2002","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/HJH.0000000000001707","article-title":"Blood pressure variability and kidney disease: another vicious circle?","volume":"36","author":"Bilo","year":"2018","journal-title":"J Hypertens"},{"key":"2023040302304223100_","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcm.2021.04.003","article-title":"Adequate blood pressure control unattainable without adequate recognition and treatment of primary aldosteronism","volume":"32","author":"Ruilope","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"2023040302304223100_","article-title":"Screening for primary aldosteronism in the diabetic population: a cohort study","author":"Tan","year":"2022","journal-title":"Intern Med J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/HYPERTENSIONAHA.120.15950","article-title":"Masked uncontrolled hypertension is accompanied by increased out-of-clinic aldosterone secretion","volume":"77","author":"Siddiqui","year":"2021","journal-title":"Hypertension"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/HJH.0000000000003049","article-title":"Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study","volume":"40","author":"Lin","year":"2021","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/HJH.0b013e32832a5ab3","article-title":"Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive","volume":"27","author":"Gosse","year":"2009","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/HJH.0000000000002007","article-title":"Increased carotid stiffness and remodelling at early stages of chronic kidney disease","volume":"37","author":"Zanoli","year":"2019","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3132\/dvdr.2009.006","article-title":"Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial","volume":"6","author":"Hanefeld","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"Ferreira","year":"2021","journal-title":"Am J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.kint.2016.12.034","article-title":"Obesity and kidney disease: from population to basic science and the search for new therapeutic targets","volume":"92","author":"Whaley-Connell","year":"2017","journal-title":"Kidney Int"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jchf.2019.04.002","article-title":"Urinalysis: a window to the heart","volume":"7","author":"McMurray","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jamacardio.2017.4987","article-title":"Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction","volume":"3","author":"de Boer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-med-041316-090654","article-title":"Heart failure with preserved ejection fraction","volume":"69","author":"Gladden","year":"2018","journal-title":"Annu Rev Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.kint.2018.05.005","article-title":"Chronic kidney disease and arrhythmias: highlights from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"94","author":"Wanner","year":"2018","journal-title":"Kidney Int"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2020030384","article-title":"Modifiable lifestyle factors for primary prevention of CKD: a systematic review and meta-analysis","volume":"32","author":"Kelly","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/jcm9061611","article-title":"Gender, albuminuria and chronic kidney disease progression in treated diabetic kidney disease","volume":"9","author":"Fernandez-Fernandez","year":"2020","journal-title":"J Clin Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ckj\/sfab210","article-title":"Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care","volume":"15","author":"Bosi","year":"2022","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1681\/ASN.2012030252","article-title":"Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2023040302304223100_","first-page":"1866","article-title":"Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-protect 2 study","volume":"32","author":"Lindhardt","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/CS20180097","article-title":"Translational science in albuminuria: a new view of","volume":"132","author":"Baldan-Martin","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1097\/HJH.0000000000002936","article-title":"Early renal and vascular damage within the normoalbuminuria condition","volume":"39","author":"Santiago-Hernandez","year":"2021","journal-title":"J Hypertens"},{"key":"2023040302304223100_","first-page":"440","article-title":"Differential metabolic profile associated with the condition of normoalbuminuria in the hypertensive population","volume":"40","author":"Santiago-Hernandez","year":"2020","journal-title":"Nefrologia (Engl Ed)"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/antiox10071100","article-title":"TCA Cycle and fatty acids oxidation reflect early cardiorenal damage in normoalbuminuric subjects with controlled hypertension","volume":"10","author":"Santiago-Hernandez","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/HYPERTENSIONAHA.116.07412","article-title":"Plasma molecular signatures in hypertensive patients with renin-angiotensin system suppression: new predictors of renal damage and De Novo albuminuria indicators","volume":"68","author":"Baldan-Martin","year":"2016","journal-title":"Hypertension"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1097\/HJH.0000000000000292","article-title":"Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression","volume":"32","author":"Ruiz-Hurtado","year":"2014","journal-title":"J Hypertens"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-016-0331-7","article-title":"Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression","volume":"15","author":"Gonzalez-Calero","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.ajkd.2019.11.004","article-title":"Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD progression in children","volume":"76","author":"Weidemann","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1038\/s41598-017-09042-2","article-title":"Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria","volume":"7","author":"Martin-Lorenzo","year":"2017","journal-title":"Sci Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trsl.2016.07.003","article-title":"Hypertensive patients exhibit an altered metabolism. A specific metabolite signature in urine is able to predict albuminuria progression","volume":"178","author":"Gonzalez-Calero","year":"2016","journal-title":"Transl Res"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"44217","DOI":"10.18632\/oncotarget.17787","article-title":"Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria","volume":"8","author":"Gonzalez-Calero","year":"2017","journal-title":"Oncotarget"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.18632\/oncotarget.14948","article-title":"Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria","volume":"8","author":"de la Cuesta","year":"2017","journal-title":"Oncotarget"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.05.148","article-title":"Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomics","volume":"196","author":"Baldan-Martin","year":"2015","journal-title":"Int J Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20150517","article-title":"Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria","volume":"130","author":"Pulido-Olmo","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ckj\/sfx002","article-title":"Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease","volume":"10","author":"Pontillo","year":"2017","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(20)30026-7","article-title":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial","volume":"8","author":"Tofte","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"15940","DOI":"10.1038\/s41598-018-34386-8","article-title":"Novel urinary biomarkers for improved prediction of progressive Egfr loss in early chronic kidney disease stages and in high risk individuals without chronic kidney disease","volume":"8","author":"Rodr\u00edguez-Ortiz","year":"2018","journal-title":"Sci Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"16915","DOI":"10.1038\/s41598-017-17083-w","article-title":"Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?","volume":"7","author":"Magalh\u00e3es","year":"2017","journal-title":"Sci Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ckj\/sfaa016","article-title":"Proteomic characterization of obesity-related nephropathy","volume":"13","author":"Wendt","year":"2020","journal-title":"Clin Kidney J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.kint.2021.06.041","article-title":"A Mendelian randomization study found causal linkage between telomere attrition and chronic kidney disease","volume":"100","author":"Park","year":"2021","journal-title":"Kidney Int"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1681\/ASN.2020111599","article-title":"Polygenic risk scores for kidney function and their associations with circulating proteome, and incident kidney diseases","volume":"32","author":"Yu","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ajhg.2018.08.004","article-title":"Genetic association of albuminuria with cardiometabolic disease and blood pressure","volume":"103","author":"Haas","year":"2018","journal-title":"Am J Hum Genet"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat Genet"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.jacc.2020.04.027","article-title":"Limitations of contemporary guidelines for managing patients at high genetic risk of coronary artery disease","volume":"75","author":"Aragam","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/CIRCULATIONAHA.118.035658","article-title":"Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction","volume":"139","author":"Khera","year":"2019","journal-title":"Circulation"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.568","article-title":"New loci associated with kidney function and chronic kidney disease","volume":"42","author":"K\u00f6ttgen","year":"2010","journal-title":"Nat Genet"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1038\/s41467-021-24491-0","article-title":"Discovery and prioritization of variants and genes for kidney function in &gt;1.2 million individuals","volume":"12","author":"Stanzick","year":"2021","journal-title":"Nat Commun"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.kint.2020.09.030","article-title":"Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline","volume":"99","author":"Gorski","year":"2021","journal-title":"Kidney Int"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"19221","DOI":"10.18632\/aging.103747","article-title":"Association of physical activity with chronic kidney disease: a systematic review and dose-response meta-analysis","volume":"12","author":"Zhu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12882-019-1586-5","article-title":"Exercise therapy improves eGFR, and reduces blood pressure and BMI in non-dialysis CKD patients: evidence from a meta-analysis","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1093\/eurjpc\/zwaa151","article-title":"Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study","volume":"29","author":"Valenzuela","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jshs.2021.03.002","article-title":"Association between physical activity and cardiovascular risk factors: dose and sex matter","volume":"10","author":"Santos-Lozano","year":"2021","journal-title":"J Sport Health Sci"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"e0195306","DOI":"10.1371\/journal.pone.0195306","article-title":"Amount and pattern of physical activity and sedentary behavior are associated with kidney function and kidney damage: The Maastricht Study","volume":"13","author":"Martens","year":"2018","journal-title":"PLoS ONE"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12933-021-01429-w","article-title":"Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk","volume":"21","author":"B\u00f6hm","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ekir.2019.04.001","article-title":"Randomized controlled trial of exercise in CKD-the RENEXC study","volume":"4","author":"Hellberg","year":"2019","journal-title":"Kidney Int Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"e14506","DOI":"10.14814\/phy2.14506","article-title":"Impact of interval walking training managed through smart mobile devices on albuminuria and leptin\/adiponectin ratio in patients with type 2 diabetes","volume":"8","author":"Sokolovska","year":"2020","journal-title":"Physiol Rep"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrneph.2016.187","article-title":"Physical inactivity: a risk factor and target for intervention in renal care","volume":"13","author":"Zelle","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"100933","DOI":"10.1016\/j.eclinm.2021.100933","article-title":"SGLT2 Inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: a systematic review and meta-analysis","volume":"36","author":"Cardoso","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.3390\/ijms22094441","article-title":"SGLT2is and renal protection: from biological mechanisms to real-world clinical benefits","volume":"22","author":"Leoncini","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2215\/CJN.14901219","article-title":"Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories","volume":"15","author":"Levin","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2020.06.018","article-title":"Relative and absolute risk reductions in cardiovascular and kidney outcomes with Canagliflozin across KDIGO risk categories: findings from the CANVAS program","volume":"77","author":"Neuen","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","article-title":"Sotagliflozin in patients with diabetes and chronic kidney disease","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac417","article-title":"Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?","volume":"43","author":"Pitt","year":"2022","journal-title":"Eur Heart J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2215\/CJN.18771220","article-title":"GLP-1 receptor agonists in diabetic kidney disease","volume":"16","author":"Michos","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-019-0812-6","article-title":"Reduction in the incidence of myocardial infarction with sodium-glucose linked cotransporter-2 inhibitors: evident and plausible","volume":"18","author":"Gilbert","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s40265-022-01746-8","article-title":"Tirzepatide: first approval","volume":"82","author":"Syed","year":"2022","journal-title":"Drugs"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/dom.14598","article-title":"The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a Scandinavian cohort study","volume":"24","author":"Ueda","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCULATIONAHA.120.051898","article-title":"Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes","volume":"143","author":"Filippatos","year":"2021","journal-title":"Circulation"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2021.05.002","article-title":"Kidney function and outcomes in patients hospitalized with heart failure","volume":"78","author":"Patel","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ejhf.2418","article-title":"Temporal trends in initiation of mineralocorticoid receptor antagonists and risk of subsequent withdrawal in patients with heart failure: a nationwide study in Denmark from 2003-2017","volume":"24","author":"Zahir","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/eurheartj\/ehac352","article-title":"Aldosterone in chronic kidney disease and renal outcomes","volume":"43","author":"Verma","year":"2022","journal-title":"Eur Heart J"},{"key":"2023040302304223100_","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/13\/1112\/49727128\/ehac683.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/13\/1112\/49727128\/ehac683.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T10:57:59Z","timestamp":1701341879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/13\/1112\/6881117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":133,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,12,7]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac683","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,12,7]]}}}